his volume in the "ULLA Series" is an introductory textbook on paediatric drug handling. Written for new pharmaceutical scientists, this book aims to give a background of paediatric pharmacy. Its scope is to give a comprehensive introduction to children's medication in terms of dosing in practice an
Paediatric drug handling
โ Scribed by Ian Costello, Paul F., Ph.D. Long, Catherine, Ph.D. Tuleu, Vincent, Ph.D. Yeung
- Publisher
- Pharmaceutical Press
- Year
- 2007
- Tongue
- English
- Leaves
- 145
- Series
- ULLA postgraduate pharmacy series
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
This volume in the ULLA Series is an introductory textbook on paediatric drug handling. Written for new pharmaceutical scientists, this book aims to give a background of paediatric pharmacy. Its scope is to give a comprehensive introduction to children's medication in terms of dosing in practice and paediatric pharmaceutics, physiological and drug disposition differences, clinical pharmacology and pharmacogenomics. Paediatric regulations around the world as well as drug licensing and clinical trials, compliance, safety and pharmacovigilance issues will also be developed
โฆ Table of Contents
Content: 1. Updates of paediatric regulations around the world
2. Paediatric formulations in practice
3. Clinical paediatric pharmacotherapy
4. Translating pharmacogenomics into drug development
5. Clinical trials in children
6. Safety of paediatric medicines.
๐ SIMILAR VOLUMES
<i>Pediatric Drug Development</i>, Second Edition, encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and o
This handbook of drugs used in pediatric cardiac care will satisfy the need for a quick reference source of common drug therapy. There are no major texts available in the field of pediatric cardiology that exclusively provide therapeutic drug information. Several sources are available that present d
<P>The treatment of pediatric patients with congenital or acquired cardiac disease remains an important challenge for physicians in charge of these patients. The challenge to practitioners is complex given that most drugs used in this field are either unlicensed or off-label and that the patient pop